MYC and ovarian carcinoma: Finally, we observed that blocking let-7d using its inhibitor increased the resistance to DFOG in shc-Myc-expressing ovarian cancer cells (SKOV3: 2.44±0.6μm vs 8.92±0.55μm, p<0.001; OVCAR3: 2.23±0.18μm vs 9.43±0.39μm, p<0.001) (Figure 5G).